351458-17-8

Basic information

• Product Name: (5-BroMo-4-Methylpyridin-3-yl)Methanol
• Synonyms: (5-BroMo-4-Methylpyridin-3-yl)Methanol;(5-Bromo-4-methylpyridin-3-yl);3-Pyridinemethanol, 5-bromo-4-methyl-
• CAS NO: 351458-17-8
• Molecular Formula: C₇H₈BrNO
• Molecular Weight: 202.04852
• Mol File: 351458-17-8.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (5-BroMo-4-Methylpyridin-3-yl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (5-BroMo-4-Methylpyridin-3-yl)Methanol(351458-17-8)
• EPA Substance Registry System: (5-BroMo-4-Methylpyridin-3-yl)Methanol(351458-17-8)

Safety Data

• Hazardous Substances Data: 351458-17-8(Hazardous Substances Data)

Usage

General Description

(5-Bromo-4-Methylpyridin-3-yl)Methanol, also known as 5-bromonicotinaldehyde, is a chemical compound with the molecular formula C7H8BrNO. It is a white to off-white solid with a molecular weight of 202.05 g/mol. (5-BroMo-4-Methylpyridin-3-yl)Methanol is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various biologically active molecules and pharmaceutical drugs. It is also used as an intermediate in the production of agrochemicals and dyes. Additionally, (5-Bromo-4-Methylpyridin-3-yl)Methanol has potential applications in the development of new materials and in the field of medicinal chemistry due to its unique chemical properties and structure.

Upstream product

• 887922-99-8 N-BOC-5-bromo-N-ethyl-4-methyl-nicotinamide 
• 351457-86-8 5-bromo-4-methyl-pyridine-3-carbaldehyde 

Downstream Products

• 677702-12-4 3-Bromo-4-methyl-5-phenoxymethylpyridine 

Relevant articles and documents

SYNTHESIS OF 5-BROMO-4-METHYL-PYRIDIN-3-YLMETHYL)-ETHYL-CARBAMIC ACID TERT-BUTYL ESTER

The present invention relates to novel synthetic methods for the preparation of intermediates of 3{5-[3-(4,6-Difluoro-1H-benzoimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-pyridin-3-ylmethyl}-ethyl-amine.

Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation

Indazole compounds that modulate and/or inhibit cell proliferation, such as the activity of protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating, e.g., kinases-dependent diseases to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.